Article
Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients.
Liver international : official journal of the International Association for the Study of the Liver - 1 Apr 2017
Eletreby Rasha, Elakel Wafaa, Said Mohamed, El Kassas Mohamed, Seif Sameh, Elbaz Tamer, El Raziky Maissa, Abdel Rehim Siham, Zaky Samy, Fouad Rabab, Gamal Eldeen Hadeel, Abdo Mahmoud, Korany Mohamed, Yosry Ayman, El Serafy Magdy, El-Sayed Manal Hamdy, ElShazly Yehia, Waked Imam, Doss Wahid, Esmat Gamal
Abstract excerpt
BACKGROUND & AIMS: Major changes have emerged during the last few years in the therapy of chronic HCV. Several direct acting antiviral agents have been developed showing potent activity with higher rates of sustained virological response, even in difficult-to-treat patients. This study explores real life experience concerning efficacy, safety and possible predictors of response for the first cohort of Egyptian...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.